Earnings Release • Dec 17, 2019
Earnings Release
Open in ViewerOpens in native device viewer
Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Company Information 17.12.2019
Vienna - Austria, 17 December 2019 - The Executive Board of the Semperit AG Holding today quantified the impairment loss in the Medical Sector (Sempermed segment) at just under EUR 50 million. The earnings after taxes for Q1-3 2019 are expected to be around EUR -35 million; the annual result will be negative as well.
As announced in the ad-hoc release on 13 November 2019, the publication of the interim Group report as of 30 September was postponed. The publication date was now set for 19 December 2019.
Further inquiry note: Monika Riedel Director Group Communications & Sustainability +43 676 8715 8620 [email protected]
Judit Helenyi Head of Investor Relations +43 676 8715 8310 [email protected]
www.semperitgroup.com
end of announcement euro adhoc --------------------------------------------------------------------------------
| issuer: | Semperit AG Holding |
|---|---|
| Modecenterstrasse 22 | |
| A-1030 Wien | |
| phone: | +43 1 79 777-310 |
| FAX: | +43 1 79 777-602 |
| mail: | [email protected] |
| WWW: | www.semperitgroup.com |
| ISIN: | AT0000785555 |
| indexes: | WBI, ATX GP, ATX PRIME |
| stockmarkets: Wien | |
| language: | English |
Have a question? We'll get back to you promptly.